Sagility Shares Surge 8% Amid Nomura's 'Buy' Rating and 40% Upside Prediction
ByAinvest
Wednesday, Mar 25, 2026 1:17 am ET1min read
NMR--
Sagility shares jumped 7.9% on BSE, reaching a high of ₹40.22 per share. Nomura initiated coverage with a 'Buy' rating and a target price of ₹55, implying a 40% upside from current levels. The brokerage believes Sagility is well-positioned to capitalize on the growing demand for technology-enabled solutions in the US healthcare sector, driven by margin pressures and regulatory complexities faced by American health insurance companies and providers.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet